Systemic Anaplastic Large Cell Lymphoma
📧 Sign up to get email alerts when something new happens for Systemic Anaplastic Large Cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-08-19FDA Approved: ADCETRIS — Original Application (SEAGEN INC.)
FDA approved ADCETRIS (brentuximab vedotin) in its original application for CD30-expressing classical Hodgkin lymphoma and systemic anaplast…
-
FDA approval · 2011-08-19FDA Approved: ADCETRIS — Supplemental Application (SEAGEN INC.)
The FDA approved a supplemental application for ADCETRIS (brentuximab vedotin) submitted by Seagen Inc.